Table 2.

Changes in Serum Cholesterol Levels with Treatment

	Baseline			Final†			% Change
	Statin	Placebo	P value*	Statin	Placebo	P value	Statin	Placebo
Total cholesterol, mg/dL	185 ± 34	187 ± 39	0.881	137 ± 7	183 ± 43	0.0001	−25.9%	−2.2%
LDL cholesterol, mg/dL	106 ± 24	110 ± 29	0.710	67 ± 17	110 ± 33	0.001	−36.8%	−0.1%
HDL cholesterol, mg/dL	49 ± 13	41 ± 10	0.130	46 ± 14	40 ± 10	0.638	−6.1%	−2.4%
Triglycerides, mg/dL‡	151 (66 – 235)	177 (87 – 226)	0.775	96 (86 – 178)	143 (90 – 224)	0.265	−36.4%	−19.2%

^*Baseline p values were determined by an unpaired t test.

^†Changes between the two groups from baseline were determined by two-way analysis of variance and non-parametric test for triglycerides.

^‡Median (interquartile range) reported.